Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Children's Hospital Boston
Sponsor:
Collaborators:
Children's Hospital Medical Center, Cincinnati
University of California, Los Angeles
Information provided by (Responsible Party):
Children's Hospital Boston
ClinicalTrials.gov Identifier:
NCT01129544
First received: May 21, 2010
Last updated: July 23, 2014
Last verified: July 2014